Trial
NCT03699176
Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Bayer
Collaborators
—
Condition
Uterine Fibroids
Intervention
Vilaprisan (BAY1002670)
Why stopped
No patient was recruited, study withdrawn for feasibility reasons.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-18